Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2025-06-11 Legal Proceedings Report
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(영업정지)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Services Commission and Korea Exchange regarding a suspension of business operations (영업정지). It is a regulatory filing detailing a specific corporate event (business suspension) and its correction. Since it does not fit into specific categories like M&A, dividends, or financial reports, and is a formal regulatory disclosure, it is classified as a Regulatory Filing (RNS).
2025-06-11 Korean
주요사항보고서(영업정지)
Legal Proceedings Report Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korea Exchange regarding a temporary suspension of business operations (영업정지) for SLS Bio. This is a regulatory disclosure of a material event affecting the company's operations, which does not fit into specific categories like financial reports, dividends, or M&A. Therefore, it falls under the 'Regulatory Filings' (RNS) category as a general regulatory announcement.
2025-06-10 Korean
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
Regulatory Filings Classification · 100% confidence The document is a short notice from the stock exchange regarding the timeline for a 'listing eligibility review' (상장적격성 실질심사) for SLS Bio. It is a regulatory announcement concerning the status of the company's listing and potential trading suspension, which does not fit into specific categories like M&A, dividends, or financial reports. Therefore, it falls under the general regulatory filing category.
2025-06-10 Korean
기타시장안내 (상장적격성 실질심사 관련 안내)
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice from the KOSDAQ market regarding the company SLS Bio. It informs shareholders about the initiation of a 'listing eligibility review' (상장적격성 실질심사) due to a suspension of business operations. Since this is a regulatory announcement regarding market status and does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2025-06-09 Korean
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
Delisting Announcement Classification · 100% confidence The document is a short regulatory notice regarding the suspension of stock trading for (주)에스엘에스바이오 due to a review of listing eligibility. It is a formal regulatory announcement issued by an exchange, which does not fit into specific categories like earnings or dividends, making it a standard regulatory filing.
2025-06-09 Korean
기업가치제고계획(자율공시)
Management Reports Classification · 100% confidence The document is a 'Corporate Value Enhancement Plan' (기업가치 제고 계획) filed as a voluntary disclosure (자율공시) by SLS Bio. It outlines future business strategies, financial targets, and shareholder return policies. While it mentions an attached file for detailed information, the document itself provides a summary of the strategic plan. Given that it is a regulatory filing regarding corporate strategy and governance/value enhancement, and does not fit into specific categories like 10-K or IR, it is best classified as a Regulatory Filing (RNS).
2025-05-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.